Evidence map›Paper›PMID 30137026›Full record

ArticleThe Journal of clinical investigation2018

Interaction between smoking and ATG16L1T300A triggers Paneth cell defects in Crohn's disease.

Ta-Chiang Liu, Justin T Kern, Kelli L VanDussen, Shanshan Xiong, Gerard E Kaiko, Craig B Wilen, Michael W Rajala, Roberta Caruso, Michael J Holtzman, Feng Gao and 4 more

Abstract read
In one paragraph

Article in The Journal of clinical investigation, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. NADScience translational medicine · 2024
    Article
  15. Article
  16. Review
  17. Crohn's disease: Why the ileum?World journal of gastroenterology · 2023
    Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Ta-Chiang LiuDepartment of Pathology and Immunology, Washington University School of Medicine, Saint Louis, Missouri, USA.
Justin T KernDepartment of Pathology and Immunology, Washington University School of Medicine, Saint Louis, Missouri, USA.
Kelli L VanDussenDepartment of Pathology and Immunology, Washington University School of Medicine, Saint Louis, Missouri, USA.
Shanshan XiongDepartment of Pathology and Immunology, Washington University School of Medicine, Saint Louis, Missouri, USA.
Gerard E KaikoDepartment of Pathology and Immunology, Washington University School of Medicine, Saint Louis, Missouri, USA.
Craig B WilenDepartment of Pathology and Immunology, Washington University School of Medicine, Saint Louis, Missouri, USA.
Michael W RajalaDepartment of Pathology, University of Michigan School of Medicine, Ann Arbor, Michigan, USA.
Roberta CarusoDepartment of Pathology, University of Michigan School of Medicine, Ann Arbor, Michigan, USA.
Michael J HoltzmanDepartment of Medicine and.
Feng GaoDepartment of Surgery, Washington University School of Medicine, Saint Louis, Missouri, USA.
Dermot Pb McGovernF. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA.
Gabriel NunezDepartment of Pathology, University of Michigan School of Medicine, Ann Arbor, Michigan, USA.
Richard D HeadDepartment of Pathology and Immunology, Washington University School of Medicine, Saint Louis, Missouri, USA.
Thaddeus S StappenbeckDepartment of Pathology and Immunology, Washington University School of Medicine, Saint Louis, Missouri, USA.

Funding

Washington University Center for Cellular ImagingP30CA091842 · NCI · WASHINGTON UNIVERSITY · PI TIMOTHY J. EBERLEIN · 2001 to 2026
$128.0M
WU INSTITUTE OF CLINICAL AND TRANSLATIONAL SCIENCESUL1TR002345 · NCATS · WASHINGTON UNIVERSITY · PI William G. Powderly · 2017 to 2026
$97.8M
Washington University Institute of Clinical and Translational SciencesUL1TR000448 · NCATS · WASHINGTON UNIVERSITY · PI EVANOFF, BRADLEY A · 2012 to 2016
$41.4M
Using polygenic scores to enhance both variant discovery, and understanding of functional consequences of genetic variation in IBD.P01DK046763 · NIDDK · CEDARS-SINAI MEDICAL CENTER · PI MCGOVERN, DERMOT PATRICK · 1992 to 2020
$31.1M
Utilizing the Phenomics of IBD to Enhance Gene DiscoveryU01DK062413 · NIDDK · CEDARS-SINAI MEDICAL CENTER · PI Dermot Patrick McGovern · 2002 to 2026
$12.2M
Preclinical Development of an Anti-Mucus DrugUH3HL123429 · NHLBI · WASHINGTON UNIVERSITY · PI HOLTZMAN, MICHAEL J · 2016 to 2018
$4.7M
Nod2: A Susceptibility Gene for Crohn's DiseaseR01DK061707 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI NUNEZ, GABRIEL · 2002 to 2017
$4.7M
PARP9-DTX3L Control Of Viral Infection and Airway DiseaseR01AI130591 · NIAID · WASHINGTON UNIVERSITY · PI HOLTZMAN, MICHAEL J · 2017 to 2021
$3.0M
IL-33 AND EXCESS MUCUS PRODUCTIONR01HL121791 · NHLBI · WASHINGTON UNIVERSITY · PI HOLTZMAN, MICHAEL J · 2014 to 2017
$1.9M
INTERFERON SIGNAL ENHANCERS AS ANTIVIRAL THERAPEUTICSR01AI111605 · NIAID · WASHINGTON UNIVERSITY · PI HOLTZMAN, MICHAEL J · 2014 to 2017
$1.8M
Role of virus-receptor interactions in determining norovirus tropism and pathogenesis in vivoK08AI128043 · NIAID · YALE UNIVERSITY · PI WILEN, CRAIG BRIAN · 2017 to 2021
$940k
DEFINING THE BASIS OF EPITHELIAL DEFECTS IN CROHN'S DISEASE PATIENTSK01DK109081 · NIDDK · WASHINGTON UNIVERSITY · PI VANDUSSEN, KELLI LYNN · 2016 to 2020
$737k
NCATS NIH HHS UL1 TR000448NCATS NIH HHS UL1 TR002345NCI NIH HHS P30 CA091842NHLBI NIH HHS R01 HL121791NHLBI NIH HHS UH3 HL123429NIAID NIH HHS K08 AI128043NIAID NIH HHS R01 AI111605NIAID NIH HHS R01 AI130591NIDDK NIH HHS K01 DK109081NIDDK NIH HHS P01 DK046763NIDDK NIH HHS R01 DK061707NIDDK NIH HHS R56 DK095820NIDDK NIH HHS U01 DK062413
6 · The paper itself

Abstract

It is suggested that subtyping of complex inflammatory diseases can be based on genetic susceptibility and relevant environmental exposure (G+E). We propose that using matched cellular phenotypes in human subjects and corresponding preclinical models with the same G+E combinations is useful to this end. As an example, defective Paneth cells can subtype Crohn's disease (CD) subjects; Paneth cell defects have been linked to multiple CD susceptibility genes and are associated with poor outcome. We hypothesized that CD susceptibility genes interact with cigarette smoking, a major CD environmental risk factor, to trigger Paneth cell defects. We found that both CD subjects and mice with ATG16L1T300A (T300A; a prevalent CD susceptibility allele) developed Paneth cell defects triggered by tobacco smoke. Transcriptional analysis of full-thickness ileum and Paneth cell-enriched crypt base cells showed the T300A-smoking combination altered distinct pathways, including proapoptosis, metabolic dysregulation, and selective downregulation of the PPARγ pathway. Pharmacologic intervention by either apoptosis inhibitor or PPARγ agonist rosiglitazone prevented smoking-induced crypt apoptosis and Paneth cell defects in T300A mice and mice with conditional Paneth cell-specific knockout of Atg16l1. This study demonstrates how explicit G+E can drive disease-relevant phenotype and provides rational strategies for identifying actionable targets.

Indexed as

Genetic Predisposition to DiseaseMutation, MissenseAnimalsApoptosisAutophagy-Related ProteinsCarrier ProteinsCrohn DiseaseFemaleHumansMaleMiceMice, KnockoutPaneth CellsPPAR gammaRosiglitazoneSmokingATG16L1 protein, humanAtg16l1 protein, mouseAutophagy-Related ProteinsCarrier ProteinsPPAR gammaPPARG protein, humanRosiglitazoneGastroenterologyImmunologyInflammatory bowel disease

Identifiers

PMID30137026
PMCPMC6205411

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.